According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.94. In 2022 the company made an earnings per share (EPS) of -HK$1.63 a decrease over its 2021 EPS that were of -HK$1.40.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$1.96 | 19.96% |
2022 | -HK$1.63 | 16.67% |
2021 | -HK$1.40 | -90.86% |
2020 | -HK$15.32 | -3.43% |
2019 | -HK$15.87 | -85.42% |
2018 | -HK$108.81 | -12.45% |
2017 | -HK$124.28 | -42.1% |
2016 | -HK$214.67 | -71.14% |
2015 | -HK$743.86 | -11.44% |
2014 | -HK$839.99 | -11.76% |
2013 | -HK$951.99 | 71.42% |
2012 | -HK$555.35 | 16.51% |
2011 | -HK$476.65 |